All In MedTech

Device Trial Radar · NCT05777317

Pain and Neurological Function Improvements With 10 kHz Spinal Cord Stimulation Treatment of Painful Diabetic Neuropathy

PDN-SENSORY: A Multi-Center Randomized Controlled Trial to Evaluate Pain and Neurological Function With 10 kHz SCS in Treatment of Painful Diabetic Neuropathy

Last checked: Nov 20, 2026Latest source record: Jun 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingRandomized with 143 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

143

Actual

Start

Apr 24, 2023

Primary completion

Mar 13, 2026

Study completion Jul 2026

Sponsor

Lead sponsor
Nevro CorpNot on our public-company list
Sponsor type
Industry
First posted
Mar 21, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 22 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this post-market study is to evaluate changes in pain and neurological function with high frequency, 10 kHz spinal cord stimulation (SCS) therapy in patients with chronic, intractable lower limb pain associated with diabetic peripheral neuropathy, a condition known as painful diabetic neuropathy (PDN). This is a multi-center, prospective, randomized controlled study to evaluate improvement in pain and neurological function in PDN patients, with neurological function assessed via objective measures. Patients will be randomized to conventional medical management (CMM) or 10 kHz SCS plus CMM.

Conditions

  • Painful Diabetic Neuropathy

Interventions

  • 10 kHz SCSDevice

    Spinal cord stimulation programmed to a frequency of 10 kHz

  • CMM aloneOther

    Conventional medical management alone

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Lower limb pain responder rateTime frame: 6 months

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Atrium Health Wake Forest Baptist

    Winston-Salem, North Carolina

  • Touchstone Interventional Pain Center

    Medford, Oregon

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.